EUVIMEDEUVIMED entdecken
Systematische Übersicht

Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review

Mohamad Al Bannoud, Tiago Dias Martins, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi, Rubens Maciel Filho, Maria Regina Wolf Maciel

Mathematical Biosciences and Engineering · 2024 · 21 (12) · 7707-7739

DOI: 10.3934/mbe.2024339 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Mathematical Biosciences and Engineering, 2024. Verfasst von Mohamad Al Bannoud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Optimization, Design, and Advanced Control, School of Chemical Engineering, Universidade Estadual de Campinas, Campinas, São Paulo, Bra…. Hauptthemen laut MEDLINE: Biomarkers, Blood Coagulation, Hemostatic Disorders, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the pursuit of personalized medicine, there is a growing demand for computational models with parameters that are easily obtainable to accelerate the development of potential solutions. Blood tests, owing to their affordability, accessibility, and routine use in healthcare, offer valuable biomarkers for assessing hemostatic balance in thrombotic and bleeding disorders. Incorporating these biomarkers into computational models of blood coagulation is crucial for creating patient-specific models, which allow for the analysis of the influence of these biomarkers on clot formation. This systematic review aims to examine how clinically relevant biomarkers are integrated into computational models of blood clot formation, thereby advancing discussions on integration methodologies, identifying current gaps, and recommending future research directions. A systematic review was conducted following the PRISMA protocol, focusing on ten clinically significant biomarkers associated with hemostatic disorders: D-dimer, fibrinogen, Von Willebrand factor, factor Ⅷ, P-selectin, prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin Ⅲ, protein C, and protein S. By utilizing this set of biomarkers, this review underscores their integration into computational models and emphasizes their integration in the context of venous thromboembolism and hemophilia. Eligibility criteria included mathematical models of thrombin generation, blood clotting, or fibrin formation under flow, incorporating at least one of these biomarkers. A total of 53 articles were included in this review. Results indicate that commonly used biomarkers such as D-dimer, PT, and APTT are rarely and superficially integrated into computational blood coagulation models. Additionally, the kinetic parameters governing the dynamics of blood clot formation demonstrated significant variability across studies, with discrepancies of up to 1, 000-fold. This review highlights a critical gap in the availability of computational models based on phenomenological or first-principles approaches that effectively incorporate affordable and routinely used clinical test results for predicting blood coagulation. This hinders the development of practical tools for clinical application, as current mathematical models often fail to consider precise, patient-specific values. This limitation is especially pronounced in patients with conditions such as hemophilia, protein C and S deficiencies, or antithrombin deficiency. Addressing these challenges by developing patient-specific models that account for kinetic variability is crucial for advancing personalized medicine in the field of hemostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersBlood CoagulationHemostatic DisordersThrombosisHumansFibrin Fibrinogen Degradation ProductsHemostasisComputer SimulationPrecision MedicinePartial Thromboplastin TimeHemophilia AProthrombin Timevon Willebrand FactorFibrinogenP-SelectinBlood Coagulation TestsVenous ThromboembolismProtein CModels, Biological

Stichwörter der Autor:innen

biomarkerscomputational modelhemostasismathematical modelingpersonalized medicinethrombosis

Substanzen

Biomarkersfibrin fragment DFibrin Fibrinogen Degradation Productsvon Willebrand FactorFibrinogenP-SelectinProtein C

Autor:innen und Institutionen

  • Laboratory of Optimization, Design, and Advanced Control, School of Chemical Engineering, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
  • Centro de Doenças Tromboembólicas, Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
  • Departamento de Engenharia Química, Universidade Federal de São Paulo, Diadema, São Paulo, Brazil.
  • Hematology and Hemotherapy Center, Instituto Nacional de Ciência e Tecnologia do Sangue, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Zitieren

APA

Bannoud, M. A., Martins, T. D., Montalvão, S. A. L., Annichino-Bizzacchi, J. M., Filho, R. M., & Maciel, M. R. W. (2024). Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review. Mathematical Biosciences and Engineering, 21(12), 7707-7739. https://doi.org/10.3934/mbe.2024339

Vancouver

Bannoud MA, Martins TD, Montalvão SAL, Annichino-Bizzacchi JM, Filho RM, Maciel MRW. Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review. Mathematical Biosciences and Engineering. 2024;21(12):7707-7739. doi:10.3934/mbe.2024339

BibTeX
@article{Bannoud2024,
  author = {Bannoud, Mohamad Al and Martins, Tiago Dias and Montalvão, Silmara Aparecida de Lima and Annichino-Bizzacchi, Joyce Maria and Filho, Rubens Maciel and Maciel, Maria Regina Wolf},
  title = {Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review},
  journal = {Mathematical Biosciences and Engineering},
  year = {2024},
  volume = {21},
  number = {12},
  pages = {7707--7739},
  doi = {10.3934/mbe.2024339}
}
Kostenlos starten →